Literature DB >> 11275368

Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma.

N Takai1, T Miyazaki, K Fujisawa, K Nasu, I Miyakawa.   

Abstract

Basic helix-loop-helix (bHLH) DNA-binding proteins have been reported to regulate tissue-specific transcription of cellular differentiation within multiple cell lineages. The Id family of helix-loop-helix proteins does not possess a basic DNA-binding domain and functions as a negative regulator of bHLH proteins by forming high-affinity heterodimers with bHLH proteins. Id proteins were originally characterized as inhibitors of DNA binding and cell differentiation. Thus, overexpression of Id proteins correlates with cell proliferation and arrested differentiation in many cell lineages. To elucidate the involvement of Id1 in endometrial carcinogenesis, we analyzed serial frozen sections for Id1 protein expression in 20 cases of endometrial carcinoma and 20 cases of normal endometria by fluorescent immunohistochemistry. We analyzed the relationship between the percentages of Id1-stained cells and the patient's characteristics, including histological grade, clinical stage, presence of invasion to >1/2 myometrium, and clinical outcome. In normal endometria, Id1 was not detected in either the proliferative or the secretory phase. There was, however, abundant Id1 immunoreactivity in the endometrial carcinoma cells. Moreover, Id1 was strongly expressed in the inflammatory cells. Scoring on the basis of the percentage of positive cells indicated that Id1 expression is significantly associated with histological grade (P<0.05) and the presence of invasion to >1/2 myometrium (P<0.05). Our results demonstrate that increased Id1 expression in endometrial carcinoma correlates with the malignant potential of this tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275368     DOI: 10.1016/s0304-3835(01)00433-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

Review 1.  Helix-loop-helix proteins in mammary gland development and breast cancer.

Authors:  Pierre-Yves Desprez; Tomoki Sumida; Jean-Philippe Coppé
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers.

Authors:  Min Khine Maw; Jiro Fujimoto; Teruhiko Tamaya
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

3.  The dietary compounds resveratrol and genistein induce activating transcription factor 3 while suppressing inhibitor of DNA binding/differentiation-1.

Authors:  Frank G Bottone; Brenda Alston-Mills
Journal:  J Med Food       Date:  2011-05-09       Impact factor: 2.786

4.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells.

Authors:  Jun Tang; Gabriel M Gordon; Maike G Müller; Madhu Dahiya; Kimberly E Foreman
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Id1 promotes tumor cell migration in nonsmall cell lung cancers.

Authors:  Raka Bhattacharya; Jeanne Kowalski; Allison R Larson; Malcolm Brock; Rhoda M Alani
Journal:  J Oncol       Date:  2010-04-18       Impact factor: 4.375

6.  Inhibitor of DNA binding-1 promotes the migration and proliferation of endothelial progenitor cells in vitro.

Authors:  Hong Wang; Yang Yu; Rui-wei Guo; Yan-kun Shi; Ming-bao Song; Jian-fei Chen; Shi-yong Yu; Yang-guang Yin; Pan Gao; Lan Huang
Journal:  Mol Cell Biochem       Date:  2009-08-22       Impact factor: 3.396

7.  Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis.

Authors:  Sylvia Fong; Yoko Itahana; Tomoki Sumida; Jarnail Singh; Jean-Philippe Coppe; Yong Liu; Peter C Richards; James L Bennington; Nancy M Lee; Robert J Debs; Pierre-Yves Desprez
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

8.  Id1 delays senescence of primary human melanocytes.

Authors:  Staci D Cummings; Byungwoo Ryu; Michael A Samuels; Xiaobing Yu; Alan K Meeker; Megan A Healey; Rhoda M Alani
Journal:  Mol Carcinog       Date:  2008-09       Impact factor: 4.784

9.  Probasin promoter-driven expression of ID1 is not sufficient for carcinogenesis in rodent prostate.

Authors:  Robert Salomon; Lei Young; Duncan Macleod; Xiao-Ling Yu; Qihan Dong
Journal:  J Histochem Cytochem       Date:  2009-03-02       Impact factor: 2.479

10.  Anti-tumor effects of an ID antagonist with no observed acquired resistance.

Authors:  Paulina M Wojnarowicz; Marta Garcia Escolano; Yun-Han Huang; Bina Desai; Yvette Chin; Riddhi Shah; Sijia Xu; Saurabh Yadav; Sergey Yaklichkin; Ouathek Ouerfelli; Rajesh Kumar Soni; John Philip; David C Montrose; John H Healey; Vinagolu K Rajasekhar; William A Garland; Jeremy Ratiu; Yuan Zhuang; Larry Norton; Neal Rosen; Ronald C Hendrickson; Xi Kathy Zhou; Antonio Iavarone; Joan Massague; Andrew J Dannenberg; Anna Lasorella; Robert Benezra
Journal:  NPJ Breast Cancer       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.